Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (U01AI069911, K23 AI136579, K24 AI141036)
National Cancer Institute (U54 CA190153)
Received: 4 June 2019
Accepted: 30 December 2019
First Online: 29 January 2020
Ethics approval and consent to participate
: This study was approved by the Moi Teaching and Referral Hospital Institutional Research and Ethics Committee, Kenya. Secondary data analysis at Massachusetts General Hospital was deemed IRB exempt by the Partners Healthcare IRB. A waiver of consent for the secondary data analysis was approved by the Partners Healthcare IRB due to the completely anonymized nature of the dataset, which did not include any patient identifiers.
: No individually identifiable data – not applicable.
: The authors declare that they have no competing interests.